Next Issue
Volume 69, December
Previous Issue
Volume 69, June
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).

Sci. Pharm., Volume 69, Issue 3 (September 2001) – 7 articles , Pages 235-389

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Readerexternal link to open them.
Order results
Result details
Select all
Export citation of selected articles as:
Abstract
4th Central European Symposium on Pharmaceutical Technology / Poster presentations
by
Sci. Pharm. 2001, 69(3), 389; https://doi.org/10.3797/scipharm.aut-01-28 - 23 Sep 2001
Viewed by 303
Abstract
Using waxy materials, several controlled release tiaprofenic acid (TA) tablets were prepared. [...] Full article
Abstract
4th Central European Symposium on Pharmaceutical Technology / Oral presentations
by
Sci. Pharm. 2001, 69(3), 256; https://doi.org/10.3797/scipharm.aut-01-27 - 23 Sep 2001
Viewed by 283
Abstract
Intravesical instillation of a drug solution is a common way of treating urinary bladder infections and superficial bladder cancer. [...] Full article
Article
TABLET FORMULATIONS OF VIABLE LACTIC ACID BACTERIA
by and
Sci. Pharm. 2001, 69(3), 249-255; https://doi.org/10.3797/scipharm.aut-01-195 - 23 Sep 2001
Viewed by 567
Abstract
The aim of this work was to develop a gastric juice-resistant tablet formulation of viable lactic acid bacteria (LAB). As excipients, hydroxypropyl-methylcellulose acetate succinate (HPMCAS) and sodium alginate were applied to enhance gastric juice-resistance, and Avicel® as used to modifytablet disintegration in [...] Read more.
The aim of this work was to develop a gastric juice-resistant tablet formulation of viable lactic acid bacteria (LAB). As excipients, hydroxypropyl-methylcellulose acetate succinate (HPMCAS) and sodium alginate were applied to enhance gastric juice-resistance, and Avicel® as used to modifytablet disintegration in the intestine. The formulation was optimized using statistical experimental
design methodology. The influence of the relevant process variables (amounts of excipients applied and compaction force) on the loss of viable cells during the tablet production, on acid stability, and on tablet disintegration time was investigated. It was found that the content of HPMCAS and the compaction force were the most important test variables for tablet preparation. They influence the
loss of bacteria during the tableting process, gastric juice resistance, and the disintegration time of tablets after incubation in artificial intestinal fluid. Avicel® had little influence on all three test parameters, while sodium alginate only affected disintegration time in phosphate buffer pH 6.8. Full article
Abstract
16th Scientific Congress of the Austrian Pharmaceutical Society/Poster presentations
by
Sci. Pharm. 2001, 69(3), 248; https://doi.org/10.3797/scipharm.aut-01-26 - 23 Sep 2001
Viewed by 259
Abstract
Nichtsteroidale Antirheumatika und Antiphlogistika vom Typ der Arylessig- und Arylpropionsäuren. [...] Full article
Article
Anatomy of the underground parts of four Echinacea-species and of Parthenium integrifolium
by
Sci. Pharm. 2001, 69(3), 237-247; https://doi.org/10.3797/scipharm.aut-01-194 - 23 Sep 2001
Cited by 4 | Viewed by 662
Abstract
Improved descriptions and detailed drawings of the most important anatomical characters of the roots of Echinacea purpurea (L.) MOENCH, E. angustifolia DC., E. pallida (NuTT.) NUTT., and of Parfhenium integrifolium L. are presented. The anatomy of the rhizome of E. [...] Read more.
Improved descriptions and detailed drawings of the most important anatomical characters of the roots of Echinacea purpurea (L.) MOENCH, E. angustifolia DC., E. pallida (NuTT.) NUTT., and of Parfhenium integrifolium L. are presented. The anatomy of the rhizome of E. purpurea, which was detected in commercial samples, and of the root of E. atrorubens NUTT., another known adulteration for pharmaceutically used Echinacea-species, is documented for the first time. The possibilities and limitations of the identification by means of microscopy are discussed. The anatomical differences between the roots of E. angustifolia, E. pallida and E. atrorubens are not
sufficient for differentiation, however, root and rhizome of E. purpurea and the root of Parthenium integrifolium appear well characterized. Because of the highly similar anatomy the microscopic proof of identity and purity of crude drugs of Echinacea must be done with uncomminuted material and the examination of cross sections.
Full article
Abstract
16th Scientific Congress of the Austrian Pharmaceutical Society/Oral presentations
by
Sci. Pharm. 2001, 69(3), 236; https://doi.org/10.3797/scipharm.aut-01-25 - 23 Sep 2001
Viewed by 303
Abstract
Diclofenac Sodium (Fig. 1) is one of the most popular nonsteroidal anti-inflammatory drugs, which is commonly used in different dosage forms, such as tables, ointments or injectabilia. [...] Full article
Abstract
Plenary lectures
by
Sci. Pharm. 2001, 69(3), 235; https://doi.org/10.3797/scipharm.aut-01-24 - 23 Sep 2001
Cited by 1 | Viewed by 327
Abstract
Recombinant proteins can be very potent, but their therapeutic application can be strongly hampered by inappropriate distribution. [...] Full article
Previous Issue
Next Issue
Back to TopTop